Neuroscan software, mHealth AND a rival for Resmed's massive CPAP profits
CMP's Chinese distributor recently acquired a stake in CMP
$13 million cap
$7.3 million sold product orders on hand - NPAT from these will hit the balance sheet this quarter and next
$35 million revenue
$1.3 million cash
Net assets $8 million
Borrowings $2.5 million
Perfect example of OBV accumulation, and at 12 month highs on high relative volume
Looking to tap into ResMed's large and growing CPAP market with its Somnolink SPAP device.
ResMed sales continue to surge and is capitalised at $7.7 billion.
Neuroscan software, mHealth AND a rival for Resmed's massive...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $53.82M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 28.0¢ | $410 | 1.464K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 20999 | 1 |
View Market Depth
| Last trade - 10.17am 18/07/2025 (20 minute delay) ? |
| CMP (ASX) Chart |